Peripheral Neuropathy Trial, Recruiting NCT07188415 Sponsor: Bopha Chrea Condition: Peripheral Neuropathy
Back to Peripheral Neuropathy

Peripheral Neuropathy Trial, Recruiting

NCT07188415
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been clinically diagnosed with CMT (Charcot-Marie-Tooth disease) and have had this confirmed through genetic testing
  • People between the ages of 12 and 75
  • People who are able to walk at a slow to moderate pace without wearing an AFO (a type of brace that supports the ankle and foot)
  • People who can read and write in English and are able to sign a written consent form
  • People joining the non-surgical group must have been prescribed an AFO brace by a doctor for use in daily activities
  • People joining the surgical group must have already had an operation to correct a CMT-related foot deformity, specifically one focused on balancing the muscles and correcting the back part of the foot

Who may not be able to join:

  • People who have other conditions or risk factors that can cause nerve damage, such as diabetes or heavy alcohol use
  • People with vision problems that have not been corrected
  • People who have a history of a muscle or bone injury that required surgery
  • People who have lost the ability to feel protective sensations in the sole of their foot
  • People who experience pain greater than 4 out of 10 while walking, or whose pain increases by more than 2 out of 10 during testing
  • People where the examiner has concerns that the individual may not be able to complete the study
  • People joining the non-surgical group who have previously had surgical correction of a CMT-related foot deformity focused on muscle balancing and hindfoot correction

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 319-356-3943

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Bopha Chrea
Registry
ClinicalTrials.gov
Start date
14 August 2025
Est. completion
1 August 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Four-Square Step Test; Self-selected Walking Velocity; Activity Specific Balance Confidence Scale; Falls Frequency Questionnaire; Lower Extremity Gait Biomechanics

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov